Robert Califf, a deputy commissioner at the FDA, says that in order to accelerate medical treatment options for diseases like Alzheimer's, we must improve our basic understanding of disease processes.
A new Battelle report examines new trends in translational science among academia-industry collaboration, and the impact it has on basic science research.
We'll explore why the next era of payer performance will depend on building a trusted data foundation that connects people, providers, and relationships across the enterprise.